Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.

Author: Chow, Sheryl L. PharmD, FAHA, Chair; Maisel, Alan S. MD, Vice Chair; Anand, Inder MD, DPhil, FAHA; Bozkurt, Biykem MD, PhD, FAHA; de Boer, Rudolf A. MD, PhD, FAHA; Felker, G. Michael MD, MHS, FAHA; Fonarow, Gregg C. MD, FAHA; Greenberg, Barry MD, FAHA; Januzzi, James L. Jr MD; Kiernan, Michael S. MD; Liu, Peter P. MD, FAHA; Wang, Thomas J. MD, FAHA; Yancy, Clyde W. MD, MSc, FAHA; Zile, Michael R. MD, FAHA; On behalf of the American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Basic Cardiovascular Sciences; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Council on Quality of Care and Outcomes Research

Page: e1054-e1091

http://ift.tt/2rm5Dhg